Evoke Pharma Vs. Revance Therapeutics Industry Stock Comparison

Sell

17

EVOK
Evoke Pharma

Last Price:

4.56

Seasonality Move:

12.83%

Sell

17

RVNC
Revance Therapeutics

Last Price:

4.32

Seasonality Move:

7.02%

Sell

17

Evoke Pharma (EVOK) is a Sell

Is Evoke Pharma a Buy, Sell or Hold?

The current Evoke Pharma [EVOK] share price is $4.37. The Score for EVOK is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
EVOK is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Sell

17

Revance Therapeutics (RVNC) is a Sell

Is Revance Therapeutics a Buy, Sell or Hold?

The current Revance Therapeutics [RVNC] share price is $4.31. The Score for RVNC is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
RVNC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

EVOK Stock Price Chart

What is Evoke Pharma's stock price today?

The Evoke Pharma share price today is $4.37
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EVOK is experiencing slight selling pressure.

RVNC Stock Price Chart

What is Revance Therapeutics's stock price today?

The Revance Therapeutics share price today is $4.31
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing slight buying pressure.

EVOK Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.1	Sell
Relative Strength Index (14 RSI):	35.88	Sell
Chaikin Money Flow:	-25306	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(4.9 - 6.06)	Sell
Bollinger Bands (100):	(4.53 - 6.19)	Sell

RVNC Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.33	Sell
Relative Strength Index (14 RSI):	38.37	Sell
Chaikin Money Flow:	647205	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(4.49 - 5.89)	Sell
Bollinger Bands (100):	(3.57 - 6.31)	Sell

EVOK Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	5.25	Sell
20-day SMA:	5.56	Sell
50-day SMA:	5.07	Sell
200-day SMA:	6.07	Sell
8-day EMA:	5.06	Sell
20-day EMA:	5.34	Sell
50-day EMA:	5.29	Sell
200-day EMA:	7.33	Sell

RVNC Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	4.66	Sell
20-day SMA:	5.18	Sell
50-day SMA:	5.48	Sell
200-day SMA:	4.64	Sell
8-day EMA:	4.55	Sell
20-day EMA:	4.98	Sell
50-day EMA:	5.21	Sell
200-day EMA:	6.14	Sell

Evoke Pharma Earnings Growth & EVOK Earnings Dates

Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $22.78 per share, and an increase next year of $4.46 per share.

Revance Therapeutics Earnings Growth & RVNC Earnings Dates

Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.51 per share, and an increase next year of $0.58 per share.

Evoke Pharma Technical Analysis

	Nov 1	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14
	Nov
	01	04	05	06	07	08	11	12	13	14
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Revance Therapeutics Technical Analysis

	Nov 1	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14
	Nov
	01	04	05	06	07	08	11	12	13	14
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):